Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.15726577 |
2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.15726577 |
3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.93666711 |
4 | negative regulation of cell killing (GO:0031342) | 4.93666711 |
5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.53416170 |
6 | DNA deamination (GO:0045006) | 3.99433665 |
7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.93431526 |
8 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.92038875 |
9 | ribosomal small subunit assembly (GO:0000028) | 3.78409733 |
10 | viral transcription (GO:0019083) | 3.76716597 |
11 | negative regulation of interleukin-12 production (GO:0032695) | 3.62634831 |
12 | translational termination (GO:0006415) | 3.60009405 |
13 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.56787211 |
14 | negative T cell selection (GO:0043383) | 3.52959630 |
15 | negative thymic T cell selection (GO:0045060) | 3.52941725 |
16 | detection of bacterium (GO:0016045) | 3.50222397 |
17 | response to peptidoglycan (GO:0032494) | 3.48974923 |
18 | detection of other organism (GO:0098543) | 3.45903224 |
19 | positive thymic T cell selection (GO:0045059) | 3.42751549 |
20 | regulation of T cell tolerance induction (GO:0002664) | 3.40888796 |
21 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.35109545 |
22 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.33991484 |
23 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.33991484 |
24 | modulation by symbiont of host immune response (GO:0052553) | 3.33991484 |
25 | positive regulation by symbiont of host defense response (GO:0052509) | 3.33991484 |
26 | modulation by symbiont of host defense response (GO:0052031) | 3.33991484 |
27 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.33991484 |
28 | protein targeting to ER (GO:0045047) | 3.33925448 |
29 | ribosomal small subunit biogenesis (GO:0042274) | 3.32417946 |
30 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.28440709 |
31 | pentose-phosphate shunt (GO:0006098) | 3.27612794 |
32 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.26530409 |
33 | cotranslational protein targeting to membrane (GO:0006613) | 3.25370229 |
34 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.23225166 |
35 | response to interleukin-15 (GO:0070672) | 3.22609398 |
36 | protein localization to endoplasmic reticulum (GO:0070972) | 3.20816619 |
37 | regulation of tolerance induction (GO:0002643) | 3.20548213 |
38 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.20494117 |
39 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.16794140 |
40 | thymic T cell selection (GO:0045061) | 3.16404603 |
41 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.15620228 |
42 | response to muramyl dipeptide (GO:0032495) | 3.15203144 |
43 | cellular response to interleukin-15 (GO:0071350) | 3.14891657 |
44 | translational elongation (GO:0006414) | 3.14873781 |
45 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.12501273 |
46 | granulocyte activation (GO:0036230) | 3.12117071 |
47 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.11918213 |
48 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.11308612 |
49 | myeloid dendritic cell differentiation (GO:0043011) | 3.10884423 |
50 | macrophage activation involved in immune response (GO:0002281) | 3.09551760 |
51 | dendritic cell chemotaxis (GO:0002407) | 3.06396881 |
52 | neutrophil activation (GO:0042119) | 3.04453357 |
53 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.04431967 |
54 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.03167618 |
55 | positive regulation of B cell differentiation (GO:0045579) | 3.02968785 |
56 | positive regulation of tolerance induction (GO:0002645) | 3.02279345 |
57 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.02248141 |
58 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.01979928 |
59 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.00524319 |
60 | regulation of antigen processing and presentation (GO:0002577) | 3.00503450 |
61 | response to type I interferon (GO:0034340) | 2.98403643 |
62 | NADPH regeneration (GO:0006740) | 2.98172616 |
63 | T cell selection (GO:0045058) | 2.97916261 |
64 | type I interferon signaling pathway (GO:0060337) | 2.96684802 |
65 | cellular response to type I interferon (GO:0071357) | 2.96684802 |
66 | myeloid dendritic cell activation (GO:0001773) | 2.94165729 |
67 | viral life cycle (GO:0019058) | 2.93944025 |
68 | negative regulation of T cell mediated immunity (GO:0002710) | 2.93636401 |
69 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.92705969 |
70 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.92053566 |
71 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.92053566 |
72 | positive regulation of antigen processing and presentation (GO:0002579) | 2.89958504 |
73 | germinal center formation (GO:0002467) | 2.87874279 |
74 | regulation of gamma-delta T cell activation (GO:0046643) | 2.87103540 |
75 | regulation of regulatory T cell differentiation (GO:0045589) | 2.87036837 |
76 | lymphocyte chemotaxis (GO:0048247) | 2.86237722 |
77 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.85331434 |
78 | response to interferon-beta (GO:0035456) | 2.84146488 |
79 | negative regulation of innate immune response (GO:0045824) | 2.83580765 |
80 | actin nucleation (GO:0045010) | 2.82847154 |
81 | regulation of chronic inflammatory response (GO:0002676) | 2.82801003 |
82 | negative regulation of viral genome replication (GO:0045071) | 2.82742834 |
83 | B cell receptor signaling pathway (GO:0050853) | 2.81228897 |
84 | positive T cell selection (GO:0043368) | 2.80635163 |
85 | detection of external biotic stimulus (GO:0098581) | 2.79816697 |
86 | immunoglobulin mediated immune response (GO:0016064) | 2.79296836 |
87 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.74967895 |
88 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.74033904 |
89 | positive regulation of type 2 immune response (GO:0002830) | 2.72433884 |
90 | cellular protein complex disassembly (GO:0043624) | 2.72356725 |
91 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.71688430 |
92 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.71434741 |
93 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.70850908 |
94 | NIK/NF-kappaB signaling (GO:0038061) | 2.70425433 |
95 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.68246179 |
96 | myeloid cell activation involved in immune response (GO:0002275) | 2.67909498 |
97 | cellular response to interferon-gamma (GO:0071346) | 2.65952117 |
98 | lymphocyte migration (GO:0072676) | 2.65654142 |
99 | negative regulation of type I interferon production (GO:0032480) | 2.65504626 |
100 | translational initiation (GO:0006413) | 2.65118722 |
101 | T-helper 1 type immune response (GO:0042088) | 2.64155705 |
102 | mature B cell differentiation (GO:0002335) | 2.63346705 |
103 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.62394685 |
104 | amyloid precursor protein catabolic process (GO:0042987) | 2.62247132 |
105 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.62067824 |
106 | nucleoside salvage (GO:0043174) | 2.61957666 |
107 | leukocyte aggregation (GO:0070486) | 2.59148993 |
108 | regulation of B cell differentiation (GO:0045577) | 2.54638271 |
109 | defense response to protozoan (GO:0042832) | 2.51772475 |
110 | cellular response to interferon-beta (GO:0035458) | 2.50910695 |
111 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.50586794 |
112 | regulation of protein heterodimerization activity (GO:0043497) | 2.50402027 |
113 | negative regulation of phagocytosis (GO:0050765) | 2.47524907 |
114 | B cell mediated immunity (GO:0019724) | 2.47508180 |
115 | maturation of SSU-rRNA (GO:0030490) | 2.46529319 |
116 | nucleotide salvage (GO:0043173) | 2.46342821 |
117 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.45008480 |
118 | response to protozoan (GO:0001562) | 2.44698846 |
119 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.43815486 |
120 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.42974630 |
121 | cellular response to exogenous dsRNA (GO:0071360) | 2.42457864 |
122 | neutrophil activation involved in immune response (GO:0002283) | 2.42214988 |
123 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.40808464 |
124 | respiratory burst (GO:0045730) | 2.39802859 |
125 | purine nucleotide salvage (GO:0032261) | 2.39685404 |
126 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.36326549 |
127 | purine-containing compound salvage (GO:0043101) | 2.32124604 |
128 | glucose catabolic process (GO:0006007) | 2.32067434 |
129 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.31402576 |
130 | protein complex disassembly (GO:0043241) | 2.30193167 |
131 | ribosomal large subunit biogenesis (GO:0042273) | 2.30165086 |
132 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.28680626 |
133 | mast cell activation (GO:0045576) | 2.26314663 |
134 | proteasome assembly (GO:0043248) | 2.26258399 |
135 | protein targeting to membrane (GO:0006612) | 2.23591979 |
136 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.23535868 |
137 | pentose metabolic process (GO:0019321) | 2.22316019 |
138 | positive regulation of interferon-alpha production (GO:0032727) | 2.22260372 |
139 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.21093539 |
140 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.20738185 |
141 | tolerance induction (GO:0002507) | 2.18796921 |
142 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.18784296 |
143 | pyrimidine-containing compound salvage (GO:0008655) | 2.18450416 |
144 | pyrimidine nucleoside salvage (GO:0043097) | 2.18450416 |
145 | hepatocyte apoptotic process (GO:0097284) | 2.17703304 |
146 | cellular response to dsRNA (GO:0071359) | 2.17268465 |
147 | regulation of response to interferon-gamma (GO:0060330) | 2.16878928 |
148 | regulation of natural killer cell differentiation (GO:0032823) | 2.14791949 |
149 | T cell migration (GO:0072678) | 2.13811976 |
150 | response to interferon-alpha (GO:0035455) | 2.12807415 |
151 | regulation of superoxide anion generation (GO:0032928) | 2.12522035 |
152 | mature B cell differentiation involved in immune response (GO:0002313) | 2.11980649 |
153 | signal peptide processing (GO:0006465) | 2.11512607 |
154 | macromolecular complex disassembly (GO:0032984) | 2.11052935 |
155 | regulation of necrotic cell death (GO:0010939) | 2.10857593 |
156 | regulation of interferon-alpha production (GO:0032647) | 2.10325245 |
157 | endosome to melanosome transport (GO:0035646) | 2.08425745 |
158 | endosome to pigment granule transport (GO:0043485) | 2.08425745 |
159 | cellular response to virus (GO:0098586) | 2.07703495 |
160 | regulation of RIG-I signaling pathway (GO:0039535) | 2.07601448 |
161 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.07359429 |
162 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.06818430 |
163 | translation (GO:0006412) | 2.06211713 |
164 | ncRNA 3-end processing (GO:0043628) | 2.05785145 |
165 | negative regulation of viral entry into host cell (GO:0046597) | 2.05241835 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.48740388 |
2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.96979386 |
3 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.58713322 |
4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.52833836 |
5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.40297862 |
6 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.38223156 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.37993119 |
8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.32552258 |
9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.28964694 |
10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.25513426 |
11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.23583302 |
12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.16621269 |
13 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.12913433 |
14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.11653158 |
15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05699669 |
16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.99419368 |
17 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98202052 |
18 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.93361157 |
19 | MYC_22102868_ChIP-Seq_BL_Human | 1.92887486 |
20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.90533172 |
21 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88273910 |
22 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.88219874 |
23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.87481358 |
24 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.86581718 |
25 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.84953277 |
26 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.84392763 |
27 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.80052567 |
28 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.75488289 |
29 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.74816020 |
30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.74317280 |
31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.70587760 |
32 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.69885705 |
33 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.68438040 |
34 | MAF_26560356_Chip-Seq_TH1_Human | 1.68419045 |
35 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.68023384 |
36 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.65296215 |
37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.64358927 |
38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.62886183 |
39 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.60595806 |
40 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.60536640 |
41 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.58048158 |
42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.57920990 |
43 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.57424540 |
44 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.56640988 |
45 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.55785062 |
46 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.55245474 |
47 | UTX_26944678_Chip-Seq_JUKART_Human | 1.54787887 |
48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.53363553 |
49 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.53174821 |
50 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.52196360 |
51 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.52015939 |
52 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.51778089 |
53 | MYB_26560356_Chip-Seq_TH2_Human | 1.50830816 |
54 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.50529925 |
55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.47535132 |
56 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45891740 |
57 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.45495010 |
58 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.43822280 |
59 | MYB_26560356_Chip-Seq_TH1_Human | 1.41380624 |
60 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.41358248 |
61 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.39629628 |
62 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.38431623 |
63 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.37782358 |
64 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.37593461 |
65 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.35406562 |
66 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.33950289 |
67 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.33938617 |
68 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32931858 |
69 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.32744208 |
70 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.32622025 |
71 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.32522778 |
72 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32444437 |
73 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.31827923 |
74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.30987331 |
75 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.30856514 |
76 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30524511 |
77 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.29966378 |
78 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.29956878 |
79 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.27749960 |
80 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.26867550 |
81 | MAF_26560356_Chip-Seq_TH2_Human | 1.26693278 |
82 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.25658654 |
83 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.25156154 |
84 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.23621410 |
85 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.23200833 |
86 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.22803347 |
87 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.22117764 |
88 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.21920394 |
89 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21068980 |
90 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.20303764 |
91 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.20172813 |
92 | GATA1_19941826_ChIP-Seq_K562_Human | 1.19490437 |
93 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.19408270 |
94 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.18387881 |
95 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18093303 |
96 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.17060631 |
97 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16065351 |
98 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.14844505 |
99 | P68_20966046_ChIP-Seq_HELA_Human | 1.14451239 |
100 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14306505 |
101 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.12860292 |
102 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.11858500 |
103 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11267708 |
104 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11224977 |
105 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09734525 |
106 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.09393752 |
107 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.08836809 |
108 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.08063863 |
109 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.07946006 |
110 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07268558 |
111 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.06699190 |
112 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05894191 |
113 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05528867 |
114 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.05310341 |
115 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.05054571 |
116 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.03969425 |
117 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.03651002 |
118 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03076483 |
119 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.03066662 |
120 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.02552966 |
121 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.01459376 |
122 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01432259 |
123 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.01280429 |
124 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01171937 |
125 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.01152295 |
126 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.00481755 |
127 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.00083988 |
128 | GATA3_26560356_Chip-Seq_TH2_Human | 0.99948488 |
129 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.98766108 |
130 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98664914 |
131 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.97337490 |
132 | GATA1_22025678_ChIP-Seq_K562_Human | 0.97308520 |
133 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97042804 |
134 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.91845077 |
135 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.90213658 |
136 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.90052244 |
137 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89388343 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.01154666 |
2 | MP0000685_abnormal_immune_system | 2.73632790 |
3 | MP0009785_altered_susceptibility_to | 2.67624042 |
4 | MP0003436_decreased_susceptibility_to | 2.53192796 |
5 | MP0005671_abnormal_response_to | 2.51849944 |
6 | MP0009840_abnormal_foam_cell | 2.46410873 |
7 | MP0005360_urolithiasis | 2.39097443 |
8 | * MP0005025_abnormal_response_to | 2.33979681 |
9 | MP0005000_abnormal_immune_tolerance | 2.31844686 |
10 | MP0003806_abnormal_nucleotide_metabolis | 2.28986839 |
11 | * MP0001800_abnormal_humoral_immune | 2.22097023 |
12 | MP0003724_increased_susceptibility_to | 2.20946273 |
13 | MP0010155_abnormal_intestine_physiology | 2.10805592 |
14 | MP0009333_abnormal_splenocyte_physiolog | 2.10587210 |
15 | MP0003763_abnormal_thymus_physiology | 2.10172437 |
16 | MP0001790_abnormal_immune_system | 2.05137506 |
17 | MP0005387_immune_system_phenotype | 2.05137506 |
18 | * MP0002452_abnormal_antigen_presenting | 2.04840892 |
19 | MP0002148_abnormal_hypersensitivity_rea | 2.04355529 |
20 | MP0006082_CNS_inflammation | 2.03069296 |
21 | * MP0002723_abnormal_immune_serum | 2.01338065 |
22 | MP0005464_abnormal_platelet_physiology | 2.00586924 |
23 | MP0003866_abnormal_defecation | 1.99933240 |
24 | MP0002419_abnormal_innate_immunity | 1.97779918 |
25 | * MP0002420_abnormal_adaptive_immunity | 1.93475301 |
26 | * MP0001819_abnormal_immune_cell | 1.92914476 |
27 | MP0002396_abnormal_hematopoietic_system | 1.92424216 |
28 | MP0000490_abnormal_crypts_of | 1.91845263 |
29 | MP0004947_skin_inflammation | 1.88107161 |
30 | MP0001873_stomach_inflammation | 1.83376901 |
31 | MP0004510_myositis | 1.79732577 |
32 | MP0002398_abnormal_bone_marrow | 1.77600340 |
33 | MP0003303_peritoneal_inflammation | 1.68996072 |
34 | MP0002166_altered_tumor_susceptibility | 1.67047397 |
35 | MP0001666_abnormal_nutrient_absorption | 1.65947397 |
36 | MP0000716_abnormal_immune_system | 1.65765770 |
37 | MP0003656_abnormal_erythrocyte_physiolo | 1.64427422 |
38 | MP0005058_abnormal_lysosome_morphology | 1.61180092 |
39 | * MP0001845_abnormal_inflammatory_respons | 1.60978613 |
40 | MP0002405_respiratory_system_inflammati | 1.60334013 |
41 | * MP0000689_abnormal_spleen_morphology | 1.57839499 |
42 | MP0003300_gastrointestinal_ulcer | 1.56794158 |
43 | MP0001853_heart_inflammation | 1.55909931 |
44 | MP0002722_abnormal_immune_system | 1.55721473 |
45 | MP0003191_abnormal_cellular_cholesterol | 1.54545411 |
46 | MP0006054_spinal_hemorrhage | 1.53005834 |
47 | MP0000465_gastrointestinal_hemorrhage | 1.52522025 |
48 | MP0003693_abnormal_embryo_hatching | 1.51447261 |
49 | MP0005397_hematopoietic_system_phenotyp | 1.49814407 |
50 | MP0001545_abnormal_hematopoietic_system | 1.49814407 |
51 | MP0002429_abnormal_blood_cell | 1.49403014 |
52 | * MP0008469_abnormal_protein_level | 1.49098956 |
53 | MP0002132_abnormal_respiratory_system | 1.48578012 |
54 | MP0009278_abnormal_bone_marrow | 1.48155904 |
55 | MP0003075_altered_response_to | 1.45783758 |
56 | MP0002139_abnormal_hepatobiliary_system | 1.44463990 |
57 | MP0000858_altered_metastatic_potential | 1.36566764 |
58 | MP0001533_abnormal_skeleton_physiology | 1.36004105 |
59 | MP0010234_abnormal_vibrissa_follicle | 1.30918152 |
60 | MP0010352_gastrointestinal_tract_polyps | 1.28972366 |
61 | MP0002998_abnormal_bone_remodeling | 1.28109162 |
62 | MP0002006_tumorigenesis | 1.26846625 |
63 | MP0002933_joint_inflammation | 1.25889936 |
64 | MP0005075_abnormal_melanosome_morpholog | 1.24341023 |
65 | MP0008260_abnormal_autophagy | 1.22321004 |
66 | MP0005365_abnormal_bile_salt | 1.22243715 |
67 | MP0000604_amyloidosis | 1.21717375 |
68 | MP0008875_abnormal_xenobiotic_pharmacok | 1.21577826 |
69 | MP0005085_abnormal_gallbladder_physiolo | 1.20133663 |
70 | MP0005166_decreased_susceptibility_to | 1.18821301 |
71 | MP0003183_abnormal_peptide_metabolism | 1.13849471 |
72 | MP0001663_abnormal_digestive_system | 1.12383266 |
73 | MP0003186_abnormal_redox_activity | 1.11943990 |
74 | MP0003172_abnormal_lysosome_physiology | 1.11798891 |
75 | MP0005023_abnormal_wound_healing | 1.10540114 |
76 | MP0000477_abnormal_intestine_morphology | 1.10108248 |
77 | MP0009643_abnormal_urine_homeostasis | 1.07813638 |
78 | MP0000609_abnormal_liver_physiology | 1.07243317 |
79 | MP0000703_abnormal_thymus_morphology | 1.06420045 |
80 | MP0009764_decreased_sensitivity_to | 1.00418695 |
81 | MP0002019_abnormal_tumor_incidence | 0.97443271 |
82 | MP0003566_abnormal_cell_adhesion | 0.97331231 |
83 | MP0005319_abnormal_enzyme/_coenzyme | 0.96485601 |
84 | MP0003828_pulmonary_edema | 0.94797588 |
85 | MP0005164_abnormal_response_to | 0.94332980 |
86 | MP0005310_abnormal_salivary_gland | 0.93980174 |
87 | MP0005451_abnormal_body_composition | 0.93604504 |
88 | MP0005083_abnormal_biliary_tract | 0.92300703 |
89 | MP0009763_increased_sensitivity_to | 0.91954507 |
90 | MP0003453_abnormal_keratinocyte_physiol | 0.90806688 |
91 | MP0008004_abnormal_stomach_pH | 0.90606125 |
92 | MP0004147_increased_porphyrin_level | 0.90454738 |
93 | MP0000343_altered_response_to | 0.89744282 |
94 | MP0009379_abnormal_foot_pigmentation | 0.88388294 |
95 | MP0003279_aneurysm | 0.87893093 |
96 | MP0004808_abnormal_hematopoietic_stem | 0.87620496 |
97 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.87336920 |
98 | MP0001542_abnormal_bone_strength | 0.86853591 |
99 | MP0002277_abnormal_respiratory_mucosa | 0.85235600 |
100 | MP0004957_abnormal_blastocyst_morpholog | 0.84641508 |
101 | MP0005381_digestive/alimentary_phenotyp | 0.84541027 |
102 | MP0005174_abnormal_tail_pigmentation | 0.83513923 |
103 | MP0000598_abnormal_liver_morphology | 0.83042639 |
104 | MP0002138_abnormal_hepatobiliary_system | 0.82581856 |
105 | MP0004381_abnormal_hair_follicle | 0.81622902 |
106 | MP0004883_abnormal_blood_vessel | 0.81393785 |
107 | MP0003690_abnormal_glial_cell | 0.79677870 |
108 | MP0005636_abnormal_mineral_homeostasis | 0.78876941 |
109 | MP0001764_abnormal_homeostasis | 0.78671948 |
110 | MP0003448_altered_tumor_morphology | 0.77195183 |
111 | MP0003795_abnormal_bone_structure | 0.76461197 |
112 | MP0002136_abnormal_kidney_physiology | 0.76336110 |
113 | MP0005165_increased_susceptibility_to | 0.75772819 |
114 | MP0001216_abnormal_epidermal_layer | 0.74126105 |
115 | MP0010329_abnormal_lipoprotein_level | 0.74102008 |
116 | MP0000249_abnormal_blood_vessel | 0.74041464 |
117 | MP0008873_increased_physiological_sensi | 0.72731632 |
118 | MP0003252_abnormal_bile_duct | 0.71306240 |
119 | MP0001243_abnormal_dermal_layer | 0.71165223 |
120 | MP0005390_skeleton_phenotype | 0.69950987 |
121 | MP0001851_eye_inflammation | 0.69271027 |
122 | MP0003045_fibrosis | 0.65339226 |
123 | MP0002877_abnormal_melanocyte_morpholog | 0.64887938 |
124 | MP0009765_abnormal_xenobiotic_induced | 0.63670081 |
125 | MP0003091_abnormal_cell_migration | 0.63530661 |
126 | MP0002332_abnormal_exercise_endurance | 0.57987835 |
127 | * MP0008874_decreased_physiological_sensi | 0.55956425 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.54067473 |
2 | Orchitis (HP:0100796) | 4.22366272 |
3 | Optic neuritis (HP:0100653) | 3.89269830 |
4 | Retrobulbar optic neuritis (HP:0100654) | 3.89269830 |
5 | Eczematoid dermatitis (HP:0000976) | 3.61253419 |
6 | Abnormality of glycolipid metabolism (HP:0010969) | 3.57525734 |
7 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.57525734 |
8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.57525734 |
9 | Petechiae (HP:0000967) | 3.55808191 |
10 | Chronic otitis media (HP:0000389) | 3.51378474 |
11 | Pustule (HP:0200039) | 3.49235835 |
12 | IgM deficiency (HP:0002850) | 3.43622732 |
13 | Recurrent abscess formation (HP:0002722) | 3.40485985 |
14 | Thrombocytosis (HP:0001894) | 3.34559185 |
15 | Pulmonary infiltrates (HP:0002113) | 3.21506421 |
16 | Vacuolated lymphocytes (HP:0001922) | 3.15606042 |
17 | Increased IgM level (HP:0003496) | 3.14250110 |
18 | Recurrent bacterial skin infections (HP:0005406) | 3.08878840 |
19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.07812029 |
20 | Recurrent bronchitis (HP:0002837) | 3.06603017 |
21 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.95797114 |
22 | Gastrointestinal infarctions (HP:0005244) | 2.91377448 |
23 | Autoimmune thrombocytopenia (HP:0001973) | 2.90920413 |
24 | Myositis (HP:0100614) | 2.86260819 |
25 | Abnormal number of erythroid precursors (HP:0012131) | 2.84888978 |
26 | Encephalitis (HP:0002383) | 2.83481432 |
27 | Abnormality of T cell physiology (HP:0011840) | 2.83467494 |
28 | Systemic lupus erythematosus (HP:0002725) | 2.80090674 |
29 | Keratoconjunctivitis sicca (HP:0001097) | 2.77177281 |
30 | Abnormality of B cell number (HP:0010975) | 2.76962862 |
31 | B lymphocytopenia (HP:0010976) | 2.76962862 |
32 | Recurrent fungal infections (HP:0002841) | 2.64662297 |
33 | Colitis (HP:0002583) | 2.61004125 |
34 | Abnormality of macrophages (HP:0004311) | 2.59608032 |
35 | Abnormality of T cells (HP:0002843) | 2.56805089 |
36 | Hypertensive crisis (HP:0100735) | 2.55753179 |
37 | Interstitial pulmonary disease (HP:0006530) | 2.55576090 |
38 | Loss of speech (HP:0002371) | 2.55041594 |
39 | Gingivitis (HP:0000230) | 2.53605703 |
40 | Increased cerebral lipofuscin (HP:0011813) | 2.53435189 |
41 | Nasal polyposis (HP:0100582) | 2.53401102 |
42 | Recurrent viral infections (HP:0004429) | 2.52358659 |
43 | Keratoconjunctivitis (HP:0001096) | 2.48763332 |
44 | Recurrent skin infections (HP:0001581) | 2.46180125 |
45 | Dysostosis multiplex (HP:0000943) | 2.42899963 |
46 | Cellulitis (HP:0100658) | 2.40599661 |
47 | Combined immunodeficiency (HP:0005387) | 2.40366997 |
48 | Hemoptysis (HP:0002105) | 2.38963502 |
49 | Abnormality of the nasal mucosa (HP:0000433) | 2.37431160 |
50 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.37120207 |
51 | Purpura (HP:0000979) | 2.36520392 |
52 | Severe combined immunodeficiency (HP:0004430) | 2.35392352 |
53 | Epistaxis (HP:0000421) | 2.33999376 |
54 | Recurrent sinusitis (HP:0011108) | 2.30592842 |
55 | Reticulocytopenia (HP:0001896) | 2.28991454 |
56 | Reduced antithrombin III activity (HP:0001976) | 2.27661099 |
57 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.27568186 |
58 | Gastrointestinal stroma tumor (HP:0100723) | 2.26189201 |
59 | Episodic fever (HP:0001954) | 2.25939978 |
60 | Increased IgE level (HP:0003212) | 2.22902538 |
61 | Vasculitis (HP:0002633) | 2.22306130 |
62 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.21969656 |
63 | Spontaneous hematomas (HP:0007420) | 2.21752071 |
64 | Gangrene (HP:0100758) | 2.19951533 |
65 | Increased serum ferritin (HP:0003281) | 2.19213267 |
66 | Amyloidosis (HP:0011034) | 2.18406526 |
67 | Hypergammaglobulinemia (HP:0010702) | 2.18273500 |
68 | Chronic diarrhea (HP:0002028) | 2.16770867 |
69 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.16399437 |
70 | Lymphopenia (HP:0001888) | 2.15610504 |
71 | Nonimmune hydrops fetalis (HP:0001790) | 2.15562987 |
72 | Joint swelling (HP:0001386) | 2.14881053 |
73 | Abnormal platelet function (HP:0011869) | 2.13054968 |
74 | Impaired platelet aggregation (HP:0003540) | 2.13054968 |
75 | Autoimmune hemolytic anemia (HP:0001890) | 2.13053445 |
76 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.12898196 |
77 | Chest pain (HP:0100749) | 2.12028018 |
78 | Xanthomatosis (HP:0000991) | 2.11651586 |
79 | Abnormality of the pleura (HP:0002103) | 2.09314995 |
80 | IgG deficiency (HP:0004315) | 2.08954245 |
81 | Papilloma (HP:0012740) | 2.08304995 |
82 | Verrucae (HP:0200043) | 2.08304995 |
83 | Premature loss of primary teeth (HP:0006323) | 2.07588091 |
84 | T lymphocytopenia (HP:0005403) | 2.07327707 |
85 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.05871096 |
86 | Anorexia (HP:0002039) | 2.05714665 |
87 | Prolonged bleeding time (HP:0003010) | 2.04796321 |
88 | Abnormality of T cell number (HP:0011839) | 2.04507092 |
89 | Mucopolysacchariduria (HP:0008155) | 2.04359753 |
90 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.04359753 |
91 | Stomatitis (HP:0010280) | 2.04245869 |
92 | Arterial thrombosis (HP:0004420) | 2.03280725 |
93 | Macrocytic anemia (HP:0001972) | 2.03135899 |
94 | Gingival bleeding (HP:0000225) | 2.02542912 |
95 | Emphysema (HP:0002097) | 2.02274343 |
96 | Meningitis (HP:0001287) | 2.01704456 |
97 | Gastrointestinal inflammation (HP:0004386) | 2.01451466 |
98 | Granulocytopenia (HP:0001913) | 2.00982266 |
99 | Pulmonary embolism (HP:0002204) | 2.00605028 |
100 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.00020868 |
101 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.00020868 |
102 | Exertional dyspnea (HP:0002875) | 1.97802999 |
103 | Leukocytosis (HP:0001974) | 1.97329487 |
104 | Glomerulopathy (HP:0100820) | 1.96464992 |
105 | Urticaria (HP:0001025) | 1.96261284 |
106 | Recurrent pneumonia (HP:0006532) | 1.96232549 |
107 | Restrictive lung disease (HP:0002091) | 1.95548979 |
108 | Pallor (HP:0000980) | 1.95001791 |
109 | Agammaglobulinemia (HP:0004432) | 1.94345623 |
110 | Abnormal platelet volume (HP:0011876) | 1.93744832 |
111 | Increased muscle lipid content (HP:0009058) | 1.93571557 |
112 | Vertebral compression fractures (HP:0002953) | 1.93525131 |
113 | Skin ulcer (HP:0200042) | 1.92215635 |
114 | Abnormality of eosinophils (HP:0001879) | 1.92023561 |
115 | Abnormality of iron homeostasis (HP:0011031) | 1.91951337 |
116 | Aplastic anemia (HP:0001915) | 1.91332931 |
117 | Inflammation of the large intestine (HP:0002037) | 1.91092991 |
118 | Increased intramyocellular lipid droplets (HP:0012240) | 1.90314644 |
119 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.89926765 |
120 | Chronic obstructive pulmonary disease (HP:0006510) | 1.88022744 |
121 | Obstructive lung disease (HP:0006536) | 1.88022744 |
122 | Panhypogammaglobulinemia (HP:0003139) | 1.87487430 |
123 | Hepatosplenomegaly (HP:0001433) | 1.86595499 |
124 | Skin rash (HP:0000988) | 1.85744751 |
125 | Poikiloderma (HP:0001029) | 1.84954749 |
126 | Eosinophilia (HP:0001880) | 1.83969164 |
127 | Ileus (HP:0002595) | 1.83358268 |
128 | Periodontitis (HP:0000704) | 1.82394104 |
129 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.81801270 |
130 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.81801270 |
131 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.81801270 |
132 | Gastrointestinal dysmotility (HP:0002579) | 1.81674457 |
133 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.80025031 |
134 | Recurrent cutaneous fungal infections (HP:0011370) | 1.80025031 |
135 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.79715765 |
136 | Mediastinal lymphadenopathy (HP:0100721) | 1.77830768 |
137 | Beaking of vertebral bodies (HP:0004568) | 1.77770706 |
138 | Erythema (HP:0010783) | 1.76571781 |
139 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.74094182 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 3.41003224 |
2 | TAOK3 | 3.19989172 |
3 | BLK | 3.12877514 |
4 | NME2 | 2.98814470 |
5 | PIM2 | 2.84583498 |
6 | TESK2 | 2.72455184 |
7 | TBK1 | 2.67861131 |
8 | ERN1 | 2.34366201 |
9 | PRPF4B | 2.32605409 |
10 | KDR | 2.12223802 |
11 | TYK2 | 2.10864670 |
12 | ZAP70 | 2.00161913 |
13 | JAK3 | 1.89814272 |
14 | STK10 | 1.79762973 |
15 | LRRK2 | 1.78445182 |
16 | IKBKE | 1.78014648 |
17 | FGFR4 | 1.72462890 |
18 | EIF2AK1 | 1.71997239 |
19 | STK16 | 1.68676522 |
20 | KIT | 1.68502124 |
21 | MST4 | 1.67828855 |
22 | TAOK2 | 1.62903345 |
23 | BTK | 1.58048206 |
24 | GRK6 | 1.51008840 |
25 | TXK | 1.50475700 |
26 | MAP3K14 | 1.46319688 |
27 | GRK7 | 1.43835712 |
28 | MAP3K13 | 1.40427757 |
29 | IRAK4 | 1.38034652 |
30 | TESK1 | 1.36304408 |
31 | EPHB1 | 1.35229869 |
32 | TEC | 1.33355480 |
33 | EEF2K | 1.31672177 |
34 | TRIB3 | 1.30617740 |
35 | IKBKB | 1.30578943 |
36 | MST1R | 1.25614619 |
37 | PKN2 | 1.23592838 |
38 | NLK | 1.21486678 |
39 | MAP2K2 | 1.21416794 |
40 | TLK1 | 1.19958708 |
41 | CSF1R | 1.16418724 |
42 | RIPK1 | 1.15997266 |
43 | SYK | 1.15684985 |
44 | FLT3 | 1.14357210 |
45 | CSK | 1.13364740 |
46 | MAP3K10 | 1.12993888 |
47 | TGFBR2 | 1.12600662 |
48 | EIF2AK3 | 1.11757773 |
49 | ITK | 1.09654124 |
50 | SMG1 | 1.08989826 |
51 | MAP3K11 | 1.07586409 |
52 | BCKDK | 1.07027024 |
53 | LCK | 1.03665152 |
54 | CDC42BPA | 0.99759287 |
55 | SCYL2 | 0.99462425 |
56 | PRKG2 | 0.97711845 |
57 | SIK1 | 0.96696310 |
58 | RPS6KA4 | 0.96572477 |
59 | IRAK3 | 0.96357602 |
60 | MAP3K8 | 0.95179026 |
61 | BUB1 | 0.93858276 |
62 | BMPR2 | 0.93435051 |
63 | PRKD2 | 0.92378540 |
64 | MATK | 0.92349259 |
65 | MAP2K3 | 0.89303595 |
66 | LYN | 0.88961049 |
67 | RPS6KB2 | 0.88802289 |
68 | PIM1 | 0.88094988 |
69 | FGR | 0.86734577 |
70 | LIMK1 | 0.85697916 |
71 | MOS | 0.84766203 |
72 | SIK3 | 0.82204727 |
73 | JAK1 | 0.80365758 |
74 | ARAF | 0.79137734 |
75 | WEE1 | 0.78297179 |
76 | FES | 0.77849193 |
77 | HIPK2 | 0.74918340 |
78 | ILK | 0.73031826 |
79 | PAK4 | 0.72959333 |
80 | HCK | 0.65122513 |
81 | EPHA3 | 0.64961747 |
82 | IRAK2 | 0.62933413 |
83 | MAP3K3 | 0.59913653 |
84 | CLK1 | 0.59700782 |
85 | DAPK3 | 0.58882263 |
86 | MAPK11 | 0.57948695 |
87 | PTK6 | 0.57429411 |
88 | MAPKAPK3 | 0.57084818 |
89 | PDK1 | 0.56587359 |
90 | TAOK1 | 0.55695518 |
91 | PDPK1 | 0.54821885 |
92 | MAPK7 | 0.54039365 |
93 | JAK2 | 0.53874775 |
94 | PAK1 | 0.52715575 |
95 | TNK2 | 0.50842740 |
96 | MAP2K6 | 0.49130181 |
97 | MAPK12 | 0.49014663 |
98 | MYLK | 0.48723530 |
99 | MAPK4 | 0.48626402 |
100 | MAPKAPK2 | 0.48542928 |
101 | FYN | 0.48341035 |
102 | BMX | 0.46573152 |
103 | PBK | 0.45700101 |
104 | TGFBR1 | 0.45252677 |
105 | MARK2 | 0.44231895 |
106 | ABL2 | 0.43914560 |
107 | MAP3K7 | 0.43618533 |
108 | SIK2 | 0.43284601 |
109 | MAPKAPK5 | 0.43224373 |
110 | RPS6KC1 | 0.42786974 |
111 | RPS6KL1 | 0.42786974 |
112 | CHUK | 0.41855756 |
113 | GRK5 | 0.41077146 |
114 | MAP3K6 | 0.40597709 |
115 | CDK4 | 0.40240902 |
116 | DDR2 | 0.39595565 |
117 | IRAK1 | 0.37760948 |
118 | PIK3CG | 0.36293853 |
119 | TRPM7 | 0.36032565 |
120 | MAPK15 | 0.35419640 |
121 | NEK2 | 0.35050543 |
122 | PRKCQ | 0.35020761 |
123 | PRKCD | 0.35007798 |
124 | RPS6KA5 | 0.34177798 |
125 | DYRK3 | 0.34092946 |
126 | CAMKK1 | 0.33780019 |
127 | RPS6KA6 | 0.32702829 |
128 | MAP3K5 | 0.31891716 |
129 | DYRK1B | 0.31676109 |
130 | ADRBK2 | 0.31255430 |
131 | MET | 0.29515655 |
132 | RIPK4 | 0.28985383 |
133 | MARK3 | 0.28231447 |
134 | MAP3K1 | 0.27668756 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 3.01940566 |
2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.92293965 |
3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.62537978 |
4 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.16818779 |
5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.10653015 |
6 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.07883235 |
7 | Proteasome_Homo sapiens_hsa03050 | 1.98198548 |
8 | DNA replication_Homo sapiens_hsa03030 | 1.84254407 |
9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.82441276 |
10 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.81946730 |
11 | Sulfur relay system_Homo sapiens_hsa04122 | 1.81930689 |
12 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.78465002 |
13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.73566636 |
14 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.72960833 |
15 | * TNF signaling pathway_Homo sapiens_hsa04668 | 1.69221525 |
16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.62073002 |
17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.59370603 |
18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.55588099 |
19 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.50180248 |
20 | Measles_Homo sapiens_hsa05162 | 1.46648149 |
21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.45619278 |
22 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.43918324 |
23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.39725524 |
24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.35797966 |
25 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.32034157 |
26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.31438972 |
27 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.29303525 |
28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.28754035 |
29 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.27017967 |
30 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.26060631 |
31 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.23833479 |
32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.21927269 |
33 | Shigellosis_Homo sapiens_hsa05131 | 1.19658967 |
34 | Legionellosis_Homo sapiens_hsa05134 | 1.19118070 |
35 | Histidine metabolism_Homo sapiens_hsa00340 | 1.17153001 |
36 | Protein export_Homo sapiens_hsa03060 | 1.14088845 |
37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.13845583 |
38 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.13670588 |
39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.11912419 |
40 | Mismatch repair_Homo sapiens_hsa03430 | 1.10337032 |
41 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.09746225 |
42 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.08746434 |
43 | Base excision repair_Homo sapiens_hsa03410 | 1.06687655 |
44 | Allograft rejection_Homo sapiens_hsa05330 | 1.05648438 |
45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.05204303 |
46 | RNA polymerase_Homo sapiens_hsa03020 | 1.04912463 |
47 | Pertussis_Homo sapiens_hsa05133 | 1.04493788 |
48 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.03425001 |
49 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.97780814 |
50 | Phagosome_Homo sapiens_hsa04145 | 0.96451593 |
51 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.95755868 |
52 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.95505735 |
53 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.95286001 |
54 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.94489879 |
55 | Galactose metabolism_Homo sapiens_hsa00052 | 0.94077656 |
56 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.93606332 |
57 | Malaria_Homo sapiens_hsa05144 | 0.93512484 |
58 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.92778433 |
59 | * Apoptosis_Homo sapiens_hsa04210 | 0.90905517 |
60 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.90709655 |
61 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.89836379 |
62 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.88870496 |
63 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.88180093 |
64 | Lysosome_Homo sapiens_hsa04142 | 0.85782876 |
65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.84889432 |
66 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.83351455 |
67 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.81983636 |
68 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.80597183 |
69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.79702043 |
70 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.78806770 |
71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78663440 |
72 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.77606949 |
73 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.76845127 |
74 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.75876396 |
75 | Influenza A_Homo sapiens_hsa05164 | 0.74378247 |
76 | Salmonella infection_Homo sapiens_hsa05132 | 0.74119137 |
77 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.72139322 |
78 | Spliceosome_Homo sapiens_hsa03040 | 0.71829989 |
79 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.71683843 |
80 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.71570333 |
81 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.71446313 |
82 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.70690999 |
83 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.70113332 |
84 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.70018549 |
85 | Asthma_Homo sapiens_hsa05310 | 0.69581751 |
86 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.68469288 |
87 | Endocytosis_Homo sapiens_hsa04144 | 0.68439480 |
88 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68383224 |
89 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.68140819 |
90 | * Hepatitis C_Homo sapiens_hsa05160 | 0.66406207 |
91 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.66354035 |
92 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.65862611 |
93 | Hepatitis B_Homo sapiens_hsa05161 | 0.65744797 |
94 | Homologous recombination_Homo sapiens_hsa03440 | 0.64303872 |
95 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.64263014 |
96 | Prion diseases_Homo sapiens_hsa05020 | 0.63678465 |
97 | Peroxisome_Homo sapiens_hsa04146 | 0.63503523 |
98 | Platelet activation_Homo sapiens_hsa04611 | 0.61972910 |
99 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.61565167 |
100 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.61465384 |
101 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59138336 |
102 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.58302592 |
103 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58296888 |
104 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.58222895 |
105 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.57730400 |
106 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.57697755 |
107 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.57629170 |
108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.57311543 |
109 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.57221885 |
110 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56689627 |
111 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56453007 |
112 | * Tuberculosis_Homo sapiens_hsa05152 | 0.55933801 |
113 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.55549198 |
114 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.55500982 |
115 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.54693548 |
116 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.54149981 |
117 | Carbon metabolism_Homo sapiens_hsa01200 | 0.51886456 |
118 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.51675324 |
119 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.51651016 |
120 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.51214078 |
121 | Bladder cancer_Homo sapiens_hsa05219 | 0.50138600 |
122 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49970456 |
123 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.48921298 |
124 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.48903662 |
125 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48330150 |
126 | Amoebiasis_Homo sapiens_hsa05146 | 0.47973380 |
127 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43429411 |
128 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.43106867 |
129 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42308488 |
130 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.42056662 |
131 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41253383 |
132 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27741100 |
133 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.27487698 |
134 | Insulin resistance_Homo sapiens_hsa04931 | 0.27025949 |
135 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.25876748 |
136 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.25748873 |
137 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.22456901 |
138 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.18063520 |
139 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.16756632 |
140 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.16358588 |
141 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.15504760 |
142 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.14408769 |
143 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.13865765 |
144 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.13015284 |
145 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.11458009 |
146 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.10702532 |